ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic OutlookGlobeNewsWire • 01/19/21
ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™GlobeNewsWire • 01/04/21
ADMA Biologics to Participate in Jefferies 2020 Virtual London Healthcare ConferenceGlobeNewsWire • 11/10/20
ADMA Biologics' (ADMA) CEO Adam Grossman on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
ADMA Biologics Reports Third Quarter 2020 Financial Results and Business HighlightsGlobeNewsWire • 11/05/20
ADMA Biologics to Report Third Quarter 2020 Financial Results and Business Highlights on November 5, 2020GlobeNewsWire • 10/29/20
Analysts Estimate Adma Biologics (ADMA) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/28/20
ADMA Biologics Announces Presentation on Respiratory Viral Infections and New Data on S. Pneumoniae at IDWeek 2020GlobeNewsWire • 10/21/20
Is the Options Market Predicting a Spike in ADMA Biologics (ADMA) Stock?Zacks Investment Research • 10/07/20
ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare ConferenceGlobeNewsWire • 09/09/20
ADMA Biologics Highlights Launch of COVID-19 ImmunoRank™ Neutralization MICRO-ELISA Assay to Detect SARS-CoV-2 Neutralizing Antibodies in PlasmaGlobeNewsWire • 09/03/20
What You Need to Know About the "Breakthrough" Coronavirus Therapy Heralded by President TrumpThe Motley Fool • 08/25/20